Is HROW overvalued right now?
Based on our 2026 models, Harrow Health, Inc. (HROW) appears overvalued at $46.15 with roughly 107.4% downside versus fair value. Confirm with valuation ratios and financials before acting.
Harrow Health, Inc. (HROW) is currently Overvalued by 107.37%
Instant valuation answer
Harrow Health, Inc. (HROW) appears overvalued by approximately 107.37% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.
- Downside (live) 107.37% (from live valuation API)
- Confidence (live) 8.5/10 (High conviction overvalued)
Confidence Score is based on the magnitude of upside or downside vs intrinsic value.
Fair value estimate
Unlock fair valueCurrent price
$46.15
Stock valuation checker
Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.
Explore Our Valuation Calculators
Why is Harrow Health, Inc. overvalued or undervalued?
Intrinsic value work anchors Harrow Health, Inc. on owner earnings and balance-sheet capacity; the current quote trades below that anchor, which frames the stock as relatively cheap on a fundamentals-first view.
Versus historical valuation bands, HROW is closer to the lower end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.
Forward market expectations are muted: the price does not require heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.
Key metrics
- P/E ratio
- 36.4x
- Revenue growth (TTM y/y)
- 27%
- Profit margin
- 35.7%
- Fair value (model)
- Unlock
Frequently asked questions — HROW
What is Harrow Health, Inc.'s intrinsic value?
Our DCF, P/E Multiple, and P/S Multiple models estimate whether HROW trades above or below fair value. At $46.15, Harrow Health, Inc. currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.
How is Harrow Health, Inc.'s intrinsic value calculated?
Tickerplace calculates HROW's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.
Is HROW undervalued right now?
A stock is undervalued when price sits below a supportable fair value range. Check whether HROW's gap aligns with fundamentals using the ratios and financial links on this page.
Related companies — valuation
Peers for HROW: open their overvalued / undervalued view.